Wonderful to see our @EUROGRAFT @COSTprogramme Action 17138 making an impact on the #chronic #GvHD field.
RT @EUROGRAFT: You can read our latest review discussing ‘New Approaches for the Treatment of Chronic Graft-Versus-Host Disease’ here: @CO…
You can read our latest review discussing ‘New Approaches for the Treatment of Chronic Graft-Versus-Host Disease’ here: @COSTprogramme #chronicgvhd #gvhd #frontiersin https://t.co/b0yZHm3tvN
RT @MaritInngj: Proud to be part of this collaborative paper on chronic GvHD, led by @NatBennett8 and Sara Galimberti! @EUROGRAFT @UniOslo…
RT @MaritInngj: Proud to be part of this collaborative paper on chronic GvHD, led by @NatBennett8 and Sara Galimberti! @EUROGRAFT @UniOslo…
RT @MaritInngj: Proud to be part of this collaborative paper on chronic GvHD, led by @NatBennett8 and Sara Galimberti! @EUROGRAFT @UniOslo…
Proud to be part of this collaborative paper on chronic GvHD, led by @NatBennett8 and Sara Galimberti! @EUROGRAFT @UniOslo_MED @Oslounivsykehus @COSTprogramme New Approaches for the Treatment of Chronic Graft-Versus-Host Disease https://t.co/bW0BhmZYb1